Is Dermata Therapeutics Inc (DRMA) Stock a Smart Investment Tuesday?

Dermata Therapeutics Inc (DRMA) stock has fallen -90.91% over the past 12 months, with an average Wall Street analyst rating of bullish buy. investor observers A unique ranking system gives DRMA stocks a score of 24 out of 100.

Its rank is primarily influenced by a short-term technical score of 0. DRMA ranks also include a long-term technical score of 1.

The overall DRMA score is 24. Find out what this means for you and get the rest of the DRMA rankings!

What Happens to DRMA Stocks Today

As of 1:28 pm on Tuesday, December 20, Dermata Therapeutics Inc (DRMA) stock is down -5.44% while the S&P 500 is up 0.3%. Over the past year, the S&P 500 has fallen -16.17% and the DRMA has fallen -90.91%. DRMA has seen him lose -$1.39 per share over the past 12 months. Click here for the full stock report for the Dermata Therapeutics Inc Stock.

Stay up to date

Subscribe to our daily morning update newsletter so you never miss any market news, moves and more you need to know.

Thank you for signing up!Ready to receive the Morning Update newsletter

Source link

Leave a Reply

%d bloggers like this: